Skip to main content

Advertisement

SpringerLink
Log in

ADHD drugs: Values that drive the debates and decisions

  • Scientific Contribution
  • Published:
Medicine, Health Care and Philosophy Aims and scope Submit manuscript

Abstract

Use of medication for treatment of ADHD (or its historical precursors) has been debated for more than forty years. Reasons for the ongoing differences of opinion are analyzed by exploring some of the arguments for and against considering ADHD a mental disorder. Relative to two important DSM criteria — that a mental disorder causes some sort of harm to the individual and that a mental disorder is the manifestation of a dysfunction in the individual — ADHD’s classification as a mental disorder is found to be contentiously value-laden. The disagreements spill over to reasoning regarding appropriate management, because justification for a drug prescription is in part predicated on the idea that the drugs manage mental disorders. These debates do not appear to be nearing resolution, so individuals offering advice, or trying to decide whether ADHD drugs are appropriate for themselves or their children, may find it helpful to compare the values underlying various perspectives with their own.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • American Academy of Pediatrics, Committee on Quality Improvement, Subcommittee on Attention-Deficit/Hyperactivity Disorder. (2001) Clinical Practice Guideline: Treatment of the School-Aged Child with Attention-Deficit/Hyperactivity Disorder. Pediatrics 108(4): 1033–1044

    Article  Google Scholar 

  • American Psychiatric Association. (2000) Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association

    Book  Google Scholar 

  • Anonymous: 2004, ‘Economic Impact of ADHD’, Medical News Today, http://www.medicalnewstoday.com/medicalnews.php?newsid = 13210, accessed June 17, 2005

  • Anonymous: 2005, ‘77 billion in Lost Income Is Attributed to ADHD Annually in the United States’ EurekAlert!, http://www.eurekalert.org/pub_releases/2005-05/pn-bi051905.php, accessed June 17, 2005

  • Barkley R.A. (1997) ADHD and the Nature of Self-Control. New York: The Guilford Press

    Google Scholar 

  • Barkley R.A., Murphy K.R. et␣al. (1996) Motor Vehicle Driving Competencies and Risks in Teens and Young Adults with Attention Deficit Hyperactivity Disorder. Pediatrics 98(6):1089–1095

    CAS  PubMed  Google Scholar 

  • Biederman J., Faraone S.V. (2005) Attention-Deficit Hyperactivity Disorder. The Lancet 366:237–248

    Article  Google Scholar 

  • Breggin P.R. (1998) Talking Back to Ritalin: What Doctors Aren’t Telling You About Stimulants for Children. Monroe, ME: Common Courage Press

    Google Scholar 

  • DiScala C., Lescohier I. et␣al. (1998) Injuries to Children with Attention Deficit Hyperactivity Disorder. Pediatrics 102(6):1415–1421

    Article  CAS  PubMed  Google Scholar 

  • Eide B.L., Eide F.F. (2006) The Mislabeled Child. The New Atlantis 12(Spring):46–59

    PubMed  Google Scholar 

  • Fulford K.W.M. (1989) Moral Theory and Medical Practice. Cambridge, UK: Cambridge University Press

    Google Scholar 

  • Fulford, K.W.M.: 2002, ‘Report to the Chair of the DSM-VI Task Force: From the Editors of Philosophy, Psychiatry, and Psychology, “Contentious and Noncontentious Evaluative Language in Psychiatric Diagnosis” (DATELINE 2010)’, in: J.Z. Sadler (ed.), Descriptions and Prescriptions: Values, Mental Disorders, and the DSMs. Baltimore: The Johns Hopkins University Press, pp. 321–362

  • Fulford, K.W.M.: 2004, ‘Values-Based Medicine: Thomas Szasz’s Legacy to Twenty-First Century Psychiatry’, in: J.A. Schaler (ed.), Szasz Under Fire: The Psychiatric Abolitionist Faces His Critics. Chicago: Open Court, pp. 57–92

  • Grady D.L., Chi H.-C. et␣al. (2003) High Prevalence of Rare Dopamine Receptor D4 Alleles in Children Diagnosed with Attention-Deficit Hyperactivity Disorder. Molecular Psychiatry 8:536–545

    Article  CAS  PubMed  Google Scholar 

  • Hoza B., Gerdes A.C. et␣al. (2004) Self-Perceptions of Competence in Children with ADHD and Comparison Children. Journal of Consulting and Clinical Psychology 72(3):382–391

    Article  PubMed  Google Scholar 

  • Kadison R. (2005) Getting an Edge — Use of Stimulants and Antidepressants in College. New England Journal of Medicine 353(11):1089–1091

    Article  CAS  PubMed  Google Scholar 

  • Lahey B.B., Applegate B. et␣al. (1994) DSM-IV Field Trials for Attention Deficit Hyperactivity Disorder in Children and Adolescents. American Journal of Psychiatry 151(11):1673–1685

    CAS  PubMed  Google Scholar 

  • Leibson C.L., Katusic S.K. et␣al. (2001) Use and Costs of Medical Care for Children and Adolescents with and Without Attention-Deficit/Hyperactivity Disorder. JAMA 285(1):60–66

    Article  CAS  PubMed  Google Scholar 

  • Litton P. (2005) ADHD, Values, and the Self. The American Journal of Bioethics 5(3):65–67

    Article  PubMed  Google Scholar 

  • Mayes S.D., Calhoun S.L. et␣al. (2000) Learning Disabilities and ADHD: Overlapping Spectrum Disorders. Journal of Learning Disabilities 33(5):417–424

    Article  CAS  PubMed  Google Scholar 

  • McCracken, J.T.: 2000, ‘Attention-Deficit Disorders’, in: B.J. Sadock and V.A. Sadock (eds.), Kaplan & Sadock’s Comprehensive Textbook of Psychiatry, Volume 2. Philadelphia: Lippincott Williams & Wilkins, pp. 2679–2688.

  • McHugh P. (1999) How Psychiatry Lost Its Way. Commentary 108(5):32–38

    Google Scholar 

  • McHugh, P. and L.R. Kass: 2003, `Exchange of Letters on Medicalization Between Leon R. Kass, M.D. and Paul McHugh, M.D, President’s Council on Bioethics, http://www.bioethics.gov/background/kass_mchugh.html, accessed January 2, 2006

  • McNeil Consumer & Specialty Pharmaceuticals. (2003) ADHD Success Stories on DVD: Once-Daily Concerta (Methylphenidate HCl). Fort Washington, PA: McNeil-PPC, Inc

    Google Scholar 

  • MTA Cooperative Group. (2004a) National Institute of Mental Health Multimodal Treatment Study of ADHD Follow-up: 24-Month Outcomes of Treatment Strategies for Attention-Deficit/Hyperactivity Disorder. Pediatrics 113(4):754–761

    Article  Google Scholar 

  • MTA Cooperative Group. (2004b) National Institute of Mental Health Multimodal Treatment Study of ADHD Follow-up: Changes in Effectiveness and Growth after the End of Treatment. Pediatrics 113(4):762–769

    Article  Google Scholar 

  • National Institutes of Health: 1998, NIH Consensus Statement: Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder (ADHD), Bethesda, Maryland: National Institutes of Health, vol. 16, No. 2, pp. 1–37

  • Rappley M.D. (2005) Attention Deficit-Hyperactivity Disorder. New England Journal of Medicine 352(2):165–173

    Article  CAS  PubMed  Google Scholar 

  • Reznek, L.: 1991, The Philosophical Defence of Psychiatry. London: Routledge

  • Sadler, J.Z.: 2002, ‘Introduction’ in: J.Z. Sadler (ed.), Descriptions and Prescriptions: Values, Mental Disorders, and the DSMs. Baltimore: The Johns Hopkins University Press, pp. 3–8.

  • Sagvolden T., Johansen E.B. et␣al. (2005). A Dynamic Developmental Theory of Attention-Deficit/Hyperactivity Disorder (ADHD) Predominantly Hyperactive/Impulsive and Combined Subtypes. Behavioral and Brain Sciences 28(3):397–468

    Article  PubMed  Google Scholar 

  • Singh I. (2005) Will the “Real Boy” Please Behave: Dosing Dilemmas for Parents of Boys with ADHD. The American Journal of Bioethics 5(3):34–47

    Article  PubMed  Google Scholar 

  • Smith, L. and K. Smith: 2001, ‘Our 14-Year-Old Son Died from Ritalin Use’ http://www.ritalindeath.com/, accessed January 20, 2006

  • Szasz, T.: 2004a, ‘Reply to Fulford’ in: J.A. Schaler (ed.), Szasz Under Fire: The Psychiatric Abolitionist Faces His Critics. Chicago: Open Court, pp. 93–117.

  • Szasz, T.: 2004b, ‘Reply to Bentall’ in: J.A. Schaler (ed.), Szasz Under Fire: The Psychiatric Abolitionist Faces His Critics. Chicago: Open Court, pp. 321–326

  • University of Medicine and Dentistry of New Jersey and Liberty Communications Network. (2005) Special Edition: Assessing the Safety of ADHD Medications: An Expert Panel Considers the Clinical Significance of Potential Adverse Effects. Medical Crossfire 6(10):1–21

    Google Scholar 

  • Wakefield J.C. (1992a) Disorder as Harmful Dysfunction: A Conceptual Critique of DSM-III-R’s Definition of Mental Disorder. Psychological Review 99(2):232–247

    Article  CAS  PubMed  Google Scholar 

  • Wakefield J.C. (1992b) The Concept of Mental Disorder: On the Boundary Between Biological Facts and Social Values. American Psychologist 47(3):373–388

    Article  CAS  PubMed  Google Scholar 

  • Wakefield, J.C.: 2002, ‘Values and the Validity of Diagnostic Criteria: Disvalued Versus Disordered Conditions of Childhood and Adolescence’ in: J.Z. Sadler (ed.), Descriptions and Prescriptions: Values, Mental Disorders, and the DSMs. Baltimore: The Johns Hopkins University Press, pp. 148–164

  • Widiger T.A, Samuel D.B. (2005) Diagnostic Categories or Dimensions? A Question for the Diagnostic and Statistical Manual of Mental Disorders — Fifth Edition. Journal of Abnormal Psychology 114(4):494–504

    Article  PubMed  Google Scholar 

  • Woodward L.J., Fergusson D.M. et␣al. (2000) Driving Outcomes of Young People with Attentional Difficulties in Adolescence. Journal of the American Academy of Child and Adolescent Psychiatry 39(5):627–634

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Philosophy, University of Minnesota, 831 Heller Hall, 271 19th Ave. S, Minneapolis, MN, 55455, USA

    Susan Hawthorne

Authors
  1. Susan Hawthorne
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Susan Hawthorne.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hawthorne, S. ADHD drugs: Values that drive the debates and decisions. Med Health Care Philos 10, 129–140 (2007). https://doi.org/10.1007/s11019-007-9056-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11019-007-9056-4

Keywords

Search

Navigation